We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-13.18%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$86.6M
AUM Growth
-$19M
Cap. Flow
-$7.16M
Cap. Flow %
-8.26%
Top 10 Hldgs %
77.71%
Holding
93
New
35
Increased
1
Reduced
9
Closed
28

Top Buys

Rank Stock Value
1
SCOR icon
Comscore
SCOR
+$29.2M
2
CARM
Carisma Therapeutics
CARM
+$12.1M
3
EMWP
Eros Media World PLC
EMWP
+$10.8M
4
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$5.04M
5
CALA
Calithera Biosciences, Inc
CALA
+$4.79M

Top Sells

Rank Stock Value
1
NSTG
NanoString Technologies, Inc.
NSTG
+$18.5M
2
BPMC
Blueprint Medicines
BPMC
+$16M
3
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$8.16M
4
GNFT
Genfit
GNFT
+$6.12M
5
SYRE icon
Spyre Therapeutics
SYRE
+$2.19M

Sector Composition

Rank Sector Weight
1 Healthcare 32.81%
2 Technology 16.82%
3 Consumer Staples 4.12%
4 Communication Services 3.85%
5 Industrials 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGSW
51
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$14K 0.02%
64,286
– –
CREXW
52
DELISTED
Creative Realities, Inc. Warrant
CREXW
$6K 0.01%
15,000
– –
AMRHW
53
DELISTED
Ameri Holdings, Inc. Warrant
AMRHW
$3K ﹤0.01%
99,500
– –
MYNDW
54
DELISTED
MYnd Analytics, Inc. Warrant
MYNDW
$3K ﹤0.01%
13,700
– –
NSPRZ
55
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$1K ﹤0.01%
48,000
– –
SNGXW
56
DELISTED
Soligenix, Inc. Warrant
SNGXW
$1K ﹤0.01%
16,599
– –
APOPW
57
DELISTED
Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
$1K ﹤0.01%
12,498
– –
BNTCW
58
DELISTED
Benitec Biopharma Limited
BNTCW
$1K ﹤0.01%
50,000
– –
CYTXZ
59
DELISTED
Cytori Therapeutics Inc Series S Warrant
CYTXZ
$1K ﹤0.01%
259,200
– –
APVO icon
60
Aptevo Therapeutics
APVO
$5.12M
– –
0
– -$703K
BPMC
61
DELISTED
Blueprint Medicines
BPMC
– –
-200,000
Closed -$16M
CRMD icon
62
PUT
CorMedix
CRMD
$584M
– –
-28,500
Closed -$269K
FCEL icon
63
FuelCell Energy
FCEL
$1.75B
– –
-92
Closed -$8K
ICCC icon
64
ImmuCell
ICCC
$99.6M
– –
-10,000
Closed -$64K
KOPN icon
65
Kopin
KOPN
$656M
– –
-1,384,944
Closed -$1.86M
LQDA icon
66
Liquidia Corp
LQDA
$7.59B
– –
-28,987
Closed -$330K
MBRX icon
67
Moleculin Biotech
MBRX
$3.07M
– –
-161
Closed -$294K
MNKD icon
68
MannKind Corp
MNKD
$1.2B
– –
-461,140
Closed -$638K
MRSN
69
DELISTED
Mersana Therapeutics
MRSN
– –
-3,359
Closed -$442K
MTNB icon
70
Matinas BioPharma
MTNB
$1.88M
– –
-18,193
Closed -$991K
SYRE icon
71
Spyre Therapeutics
SYRE
$8.57B
– –
-10,862
Closed -$2.19M
VTVT icon
72
vTv Therapeutics
VTVT
$128M
– –
-30,729
Closed -$2.1M
GRCE
73
Grace Therapeutics
GRCE
$33.7M
– –
-1,281
Closed -$63K
RNTX
74
Rein Therapeutics
RNTX
$63.1M
– –
-2,831
Closed -$110K
SCPX
75
DELISTED
Scorpius Holdings, Inc.
SCPX
– –
-12
Closed -$440K
1 2
3
4

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q2 2019 Portfolio in Review

As of Q2 2019, CVI Holdings held 93 positions worth $86.6M, down 18% from $106M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

CVI Holdings withdrew a net $7.16M in Q2 2019, closing 28 positions and reducing 9 holdings. Its most notable exit was NanoString Technologies, Inc., an estimated $18.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 68% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, CVI Holdings opened a new position in Comscore worth $14.1M.

  • CVI Holdings's largest Q2 2019 buy was Comscore: 136,426 shares worth $14.1M.
  • CVI Holdings added most to Eros Media World PLC in Q2 2019, an estimated $10.8M increase.
  • CVI Holdings's biggest Q2 2019 reduction was Genfit, cutting an estimated $6.12M.
  • CVI Holdings fully exited NanoString Technologies, Inc. in Q2 2019, selling an estimated $18.5M.
  • CVI Holdings's ten largest holdings make up 78% of its $86.6M portfolio in Q2 2019.
  • CVI Holdings opened 35 new positions and closed 28 in Q2 2019.
  • CVI Holdings's portfolio value fell 18% quarter-over-quarter to $86.6M.

Based on CVI Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.